Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. Available vaccines are now available for distribution […]
Read MoreWe are currently living in the “golden age” of biotechnology. Scientific advances have created new ways to treat and prevent diseases that were previously only thought possible by imagination alone. The biotech sector is also presenting exciting opportunities for investors, as companies with both strong drug candidate pipelines and winning drugs already on the market […]
Read MorePlus, Royal Caribbean reported a wider-than-expected loss as the COVID delta variant slows bookings, Kroger is teaming up with Kitchen United to put ghost kitchens in its grocery stores, and Zymergen shares plummet after company says product revenues would be “immaterial” in 2022.
Read MoreBuy Price: $46.50 or better Sell Price: TradersPro Sell Signal Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The stocks founds in the One Hot Stock category use […]
Read MorePlus, the S&P 500 is hovering near its record ahead of a busy earnings week with some of tech’s biggest names reporting, Bitcoin surged to nearly $39,000 on speculation that Amazon may soon accept cryptocurrencies as payment, and BioNTech said it plans to develop an mRNA vaccine for malaria.
Read MoreBioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial […]
Read MoreBuy Price: $235.00 or better Sell Signal: TradersPro Sell Signal Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 […]
Read MorePlus, the national average for gas jumped above $3 per gallon as the Colonial Pipeline remains mostly offline, Domino’s Pizza shares jump as Bill Ackman revealed 6% stake in the chain, and Wendy’s delivered an earnings beat.
Read MorePlus, Nikola shares are up after announcing a collaboration on hydrogen fueling stations with TravelCenters of America, American Airlines and Southwest Airlines reported earnings, and Amazon could soon bring its cashierless checkout technology to its full-size grocery stores.
Read MoreBuy Price: $250.00 or better Sell Price: TradersPro Sell Signal Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company’s vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and […]
Read MoreBuy Price: $38.00 or better Sell Price: TradersPro Sell Signal Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company’s lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer’s disease (AD), Parkinson’s disease, Alzheimer’s disease in Down Syndrome, and other chronic neurodegenerative […]
Read MoreBuy Price: $80.00 or better Sell Price: TradersPro Sell Signal Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; […]
Read MorePlus, President Trump was impeached by the House for a second time, Delta shares are up even after reporting its worst year ever, and Yum Brands shares are up after its Taco Bell chain said it was bringing potatoes back.
Read MorePlus, Target saw its sales rise 17% during the holiday period, while Urban Outfitters saw its holiday sales fall, and Intel’s Swan is stepping down.
Read More